2009
DOI: 10.1111/j.1472-765x.2009.02723.x
|View full text |Cite
|
Sign up to set email alerts
|

Epitope mapping of pathogenicLeptospiraLipL32

Abstract: Aims:  To identify LipL32 epitopes and to evaluate their capability to recognize specific antibodies using ELISA. Methods and Results:  Epitope mapping by means of a library of overlapping peptide fragments prepared by simultaneous and parallel solid phase peptide synthesis on derivatized cellulose membranes (SPOT synthesis) was carried out. Eighty‐seven overlapping decapentapeptides corresponding to the complete sequence of LipL32 were synthesized. According to spot‐image intensities, the most reactive sequen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
14
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 20 publications
0
14
1
Order By: Relevance
“…38 Recently, human antibody epitopes have been characterized for LipL32. 29 They consist of residues 132-158 and 162-186 ( Fig. 5c and d).…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…38 Recently, human antibody epitopes have been characterized for LipL32. 29 They consist of residues 132-158 and 162-186 ( Fig. 5c and d).…”
Section: Discussionmentioning
confidence: 97%
“…The LipL32 structure is shown in cartoon representation in green with residues 132-158 shown in pink. 29 (d) Epitope 2. The LipL32 structure is shown in cartoon representation in green with residues 162-186 shown in pink.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We previously used a similar method to compare sera from mice immunized with one PspA variant as a recombinant protein and as a DNA vaccine (34). This technique has also been used successfully to screen epitopes of antigens from other pathogens (35,36). The present study tested sera from mice immunized with several variants of PspA and PspC3 to identify the most immunogenic epitopes.…”
mentioning
confidence: 99%
“…Due to their inability to elicit long term immunity against different pathogenic serovars, efforts have shifted to search for subunit vaccine candidates that can provide heterologous protection (Zuerner et al, 2000). Several outer membrane proteins and immunoglobulin-like proteins have been reported to provide protection against challenge with several Leptospira organisms (Lottersberger et al, 2009). Many of the protections claimed are not clear cut, due to inappropriate statistical analysis, inadequate challenge dose and virulence of the challenge strain and number of animals used (Adler and Klaasen, 2015).…”
Section: Discussionmentioning
confidence: 99%